Skip to main content
# Title Research Member Research Year
31 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Dr. Doaa Fathi Hagag Ahmed 2022
32 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Asmaa Mohamed Zahran Omar 2022
33 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
34 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Israa Mostafa Kamal Mohammed 2022
35 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Dalia Osama Mohamed Ahmed 2022
36 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Dr. Iman Hassan Ahmed Hamada 2022
37 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Prof. Eman Massad Zaki El-Hefny 2022
38 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
39 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Dr. Asmaa Mohamed Zahran Omar 2022
40 Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022